Thomas Stephen Basil insider trades
Thomas Stephen Basil has filed 10 Form 4s with the SEC that we hold, all for Climb Bio, Inc. (CLYM), as Director. Across all of them we count 0 purchases worth $0 and 5 sales worth $2.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($2.2M). The largest single trade was a sale of 100,000 shares of Climb Bio, Inc. worth $1.4M, dated 2026-09-15. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2024-06-27 and the latest 2026-09-17.
Climb Bio, Inc. (CLYM)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-12 | S, sale reported on Form 4 | 90,000 | $470.7K | 2026-02-17 |
| 2026-02-13 | S, sale reported on Form 4 | 10,000 | $58.1K | 2026-02-17 |
| 2026-02-25 | S, sale reported on Form 4 | 33,687 | $235.8K | 2026-02-27 |
| 2026-02-26 | S, sale reported on Form 4 | 16,313 | $114.4K | 2026-02-27 |
| 2026-09-15 | S, sale reported on Form 4 | 100,000 | $1.4M | 2026-09-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2027962) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms